Quantum materials, materials exhibiting physical behavior governed by the laws of quantum mechanics, have proved promising ...

Parties discussed information provided by Newron and changes needed by FDA to consider re-start of enrollment in ENIGMA-TRS 2 ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

Summary: Patients surviving severe traumatic brain injuries often enter states designated as Prolonged Disorders of Consciousness (PDoC) or Locked-In Syndrome (LIS). For decades, standard bedside ...

It's built like a tank and sounds the bomb ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...

The regulatory approved CELZ-Biodefense platform is designed to scale to at least 1,000 veterans through AI-enabled mobile-app data collection and field-capable logistics Proprietary CELZ-Biodefense ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from ...

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help ...